Veerle Stouten (V Stouten)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Rheumatoid Arthritis

Disease Activity

Interstitial Lung Disease

Top Venues

Annals of the rheumatic diseases

BMC research notes

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Elias Vermeiren, Joris Adriaan Frank van Loenhout, Léonore Nasiadka, Veerle Stouten, Matthieu Billuart, Izaak Van Evercooren, Lucy Catteau, Pierre Hubin
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium. BMC research notes 16 (1) (2023)
Veerle Stouten, Pierre Hubin, Freek Haarhuis, Joris A F van Loenhout, Matthieu Billuart, Ruben Brondeel, Toon Braeye, Herman Van Oyen, Chloé Wyndham-Thomas, Lucy Catteau
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium. Viruses 14 (4) (2022)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir et al. Annals of the rheumatic diseases (2021)
Diederik De Cock, Sofia Pazmino, S Pazmino, Delphine Bertrand, Veerle Stouten, René Westhovens, Patrick Verschueren
Belgian rheumatologists' preferences regarding measures of disease activity in patients with rheumatoid arthritis: results from a mixed-methods study. Rheumatology international (2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial. Annals of the rheumatic diseases (2021)